Vistra (NYSE:VST – Free Report) had its price objective increased by Royal Bank of Canada from $105.00 to $141.00 in a research report sent to investors on Thursday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Several other brokerages also recently commented on VST. Morgan Stanley raised their target […]

Keyera (TSE:KEY – Free Report) had its target price lifted by Royal Bank of Canada from C$44.00 to C$45.00 in a research report report published on Thursday morning, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. Several other research firms also recently weighed in on KEY. Jefferies Financial Group upped their […]

Citizens Financial Group (NYSE:CFG – Free Report) had its target price cut by Evercore ISI from $47.00 to $46.00 in a report released on Wednesday, Benzinga reports. They currently have an in-line rating on the bank’s stock. Several other equities research analysts have also issued reports on CFG. Jefferies Financial Group lifted their price target […]

Cardinal Energy (TSE:CJ – Get Free Report) had its price target decreased by investment analysts at BMO Capital Markets from C$7.50 to C$7.00 in a research report issued on Friday, BayStreet.CA reports. BMO Capital Markets’ price target indicates a potential upside of 5.90% from the stock’s previous close. A number of other analysts have also […]

Royal Gold (NASDAQ:RGLD – Get Free Report) (TSE:RGL) had its price target lifted by equities research analysts at Jefferies Financial Group from $141.00 to $154.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has a “hold” rating on the basic materials company’s stock. Jefferies Financial Group’s price […]

Ollie’s Bargain Outlet (NASDAQ:OLLI – Free Report) had its target price boosted by Royal Bank of Canada from $100.00 to $106.00 in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Other equities research analysts have also recently issued reports about the stock. […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target dropped by equities researchers at Royal Bank of Canada from $85.00 to $80.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price objective would indicate a […]

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target upped by equities research analysts at Royal Bank of Canada from $74.00 to $75.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target suggests a potential […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lowered by Royal Bank of Canada from $136.00 to $133.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of […]